医学辅助生殖后的胎儿生长障碍:源于母亲背景还是技术?一项法国全国队列研究
这项回顾性全国队列研究利用法国国家卫生系统数据库2013至2017年数据,比较新鲜胚胎移植、冻融胚胎移植、宫内授精和自然受孕后的胎儿生长障碍风险。多因素分析显示,与自然受孕相比,新鲜胚胎移植和宫内授精后小于胎龄儿风险升高,冻融胚胎移植后小于胎龄儿风险降低而大于胎龄儿风险升高。
要点
- 与自然受孕相比,新鲜胚胎移植后小于胎龄儿风险升高(aOR 1.26),冻融胚胎移植后降低(aOR 0.79)。
- 冻融胚胎移植后大于胎龄儿风险升高(aOR 1.32),人工周期较排卵周期更高(aOR 1.25)。
- 宫内授精后小于胎龄儿风险轻度升高(aOR 1.08)。
核心结论
- 研究提示医学辅助生殖技术对小于胎龄儿和大于胎龄儿风险的影响独立于母亲背景及产科或新生儿疾病。
- 病理生理机制仍知之甚少,应进一步评估,胚胎阶段和冷冻技术的影响也应进一步评估。
研究设计与样本
- 回顾性全国队列研究,使用法国国家卫生系统数据库2013至2017年数据。
- 按妊娠来源分为四组:新鲜胚胎移植(n=45,201)、冻融胚胎移植(n=18,845)、宫内授精(n=20,179)和自然受孕(n=3,412,868)。
- 胎儿生长障碍根据按孕龄和性别校正的体重分布百分位定义:小于胎龄儿为低于第10百分位,大于胎龄儿为高于第90百分位。
- 采用单因素和多因素逻辑回归模型分析。
主要发现
- 与自然受孕相比,新鲜胚胎移植后小于胎龄儿风险升高(aOR 1.26 [1.22-1.29]),宫内授精后也升高(aOR 1.08 [1.03-1.12]),冻融胚胎移植后降低(aOR 0.79 [0.75-0.83])。
- 与自然受孕相比,冻融胚胎移植后大于胎龄儿风险升高(aOR 1.32 [1.27-1.38]),人工周期较排卵周期更高(aOR 1.25 [1.15-1.36])。
- 在无任何产科或新生儿疾病的出生亚组中,新鲜胚胎移植或宫内授精后小于胎龄儿风险仍升高(aOR 1.23 [1.19-1.27] 或 1.06 [1.01-1.11]),冻融胚胎移植后大于胎龄儿风险仍升高(aOR 1.36 [1.30-1.43])。
局限性
- 病理生理机制仍知之甚少,应进一步评估。
- 胚胎阶段和冷冻技术的影响也应进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What part do maternal context and medically assisted reproduction (MAR) techniques play in the risk of fetal growth disorders? DESIGN: This retrospective nationwide cohort study uses data available in the French National Health System database and focuses on the period from 2013 to 2017. Fetal growth disorders were divided into four groups according to the origin of pregnancy: fresh embryo transfer (n = 45,201), frozen embryo transfer (FET, n = 18,845), intrauterine insemination (IUI, n = 20,179) and natural conceptions (n = 3,412,868). Fetal growth disorders were defined from the percentiles of the weight distribution according to gestational age and sex: small and large for gestational age (SGA and LGA) if <10th and >90th percentiles, respectively. Analyses were performed using univariate and multivariate logistic models. RESULTS: Compared with births following natural conception, multivariate analysis showed that the risk of SGA was higher for births following fresh embryo transfer and IUI (adjusted odds ratio [aOR] 1.26 [1.22-1.29] and 1.08 [1.03-1.12], respectively) and significantly lower following FET (aOR 0.79 [0.75-0.83]). The risk of LGA was higher for births following FET (aOR 1.32 [1.27-1.38]), especially in artificial cycles when compared with ovulatory cycles (aOR 1.25 [1.15-1.36]). In the subgroup of births without any obstetrical or neonatal morbidity, the same increased risk of SGA and LGA were observed following fresh embryo transfer or IUI and FET (aOR 1.23 [1.19-1.27] or 1.06 [1.01-1.11] and aOR 1.36 [1.30-1.43], respectively). CONCLUSIONS: An effect of MAR techniques on the risks for SGA and LGA is suggested independently from maternal context and obstetrical or neonatal morbidities. Pathophysiological mechanisms remain poorly understood and should be further evaluated, as well as the influence of embryonic stage and freezing techniques.
引用
- Sermondade N, Hesters L, De Mouzon J, et al. Fetal growth disorders following medically assisted reproduction: due to maternal context or techniques? A national French cohort study. Reprod Biomed Online. 2023. PMID: 36906455. doi:10.1016/j.rbmo.2023.01.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。